Page last updated: 2024-11-13
tropaeolin oo
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
tropaeolin OO: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 23668839 |
| SCHEMBL ID | 218141 |
| MeSH ID | M0047690 |
Synonyms (48)
| Synonym |
|---|
| benzenesulfonic acid, 4-[[4-(phenylamino)phenyl]azo]-, monosodium salt |
| tertracid orange iv |
| orange n |
| tropaeolin oo |
| solar orange iv |
| diphenylamine orange |
| orange iv |
| sodium p-diphenylamino-azobenzenesulfonate |
| hispacid orange iv |
| orange 4 lake |
| tropeolin oo |
| 554-73-4 |
| acid yellow d |
| nsc-10456 |
| orange gs |
| c.i. 13080 |
| c.i. acid orange 5, monosodium salt |
| c.i. acid orange 5 |
| A0576 |
| acid orange 5 |
| AKOS005111000 |
| FT-0682673 |
| einecs 209-071-4 |
| sodium 4-((4-(anilino)phenyl)azo)benzenesulphonate |
| benzenesulfonic acid, p-((p-anilinophenyl)azo)-, sodium salt |
| unii-vr8q3r288w |
| benzenesulfonic acid, p-((p-anilinophenyl)azo)-, monosodium salt |
| vr8q3r288w , |
| nsc 10456 |
| benzenesulfonic acid, 4-(2-(4-(phenylamino)phenyl)diazenyl)-, sodium salt (1:1) |
| benzenesulfonic acid, 4-((4-(phenylamino)phenyl)azo)-, monosodium salt |
| AKOS015903188 |
| 4-(2-(4-(phenylamino)phenyl)diazenyl)benzenesulfonic acid sodium salt (1:1) |
| tropaeolin oo [mi] |
| ci-13080 |
| SCHEMBL218141 |
| sodium 4-[(4-anilinophenyl)diazenyl]-benzenesulfonate |
| DTXSID8060294 |
| sodium 4-[(4-anilinophenyl)diazenyl]benzene-1-sulfonate |
| orangeiv |
| AKOS025116979 |
| 4-(4-anilinophenylazo)benzenesulfonic acid sodium salt |
| mfcd00038130 |
| sodium (e)-4-((4-(phenylamino)phenyl)diazenyl)benzenesulfonate |
| Q6270611 |
| sodium;4-[(4-anilinophenyl)diazenyl]benzenesulfonate |
| A870183 |
| 4-[(4-anilinophenyl)azo]benzenesulfonic acid sodium salt |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " The proposed methods have been applied successfully for the analysis of the drug in its dosage forms." | ( Extractive spectrophotometric methods for determination of zolmitriptan in tablets. Aydogmus, Z; Inanli, I, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 28.39
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (28.39) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||